Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 26, 2026

New Crypto Pepeto DeFi Exchange Update While Dogecoin Nears $0.10 Breakout and Shiba Inu Whales Stack 82 Billion Tokens

View original at globenewswire.com
New Crypto Pepeto DeFi Exchange Update While Dogecoin Nears $0.10 Breakout and Shiba Inu Whales Stack 82 Billion Tokens Dubai, UAE, April 25, 2026 (GLOBE NEWSWIRE) -- Pepeto shipped a complete DeFi exchange layer during its presale, a first for any new crypto meme coin before listing day, and the traction behind it kee…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Glauber Contessoto loaded his savings into DOGE at four cents and saw it clear $3 million in weeks

    60% confidence
  • Pepeto ships a zero-fee DEX, cross-chain bridge, and AI contract scanner, all verified by SolidProof before listing, with 178% APY staking live at $0.0000001866 presale price

    60% confidence
  • Pepeto's AI engine reviews every smart contract before a trade clears and assigns a risk score before capital is exposed

    60% confidence
  • No meme coin has shipped this level of products before exchange listing day

    60% confidence
  • PepetoSwap charges zero swap fees versus 0.3% or more on Uniswap or PancakeSwap

    60% confidence
  • The meme coin sector gained 20% in April but Dogecoin and Shiba Inu remain 87% and 93% below their all-time highs

    60% confidence
  • Rob placed $8,000 into SHIB in early 2021; months later his stack crossed $1.5 million and he took $500,000 and walked away from his job

    60% confidence
  • The builder behind the original Pepe token, who scaled it past $7 billion in market cap, runs the Pepeto team

    60% confidence
  • Pepeto's cross-chain bridge moves tokens across Ethereum, BNB Chain, and Solana at zero cost, while competitors charge $15 to $50

    60% confidence
  • Dogecoin's $1 price target would require $140 billion in market cap that zero utility cannot sustain

    60% confidence
  • Pepeto raised $9,540,000 at a Fear Index of 23 — during extreme fear, not euphoria

    60% confidence
  • Dogecoin still depends entirely on one person's next social media post and Shiba Inu moves on hype alone

    60% confidence
  • Pepeto shipped a complete DeFi exchange layer during its presale, a first for any new crypto meme coin before listing day

    60% confidence
  • Pepeto generates demand every time a trader uses the platform, unlike hype-driven meme coins

    60% confidence
  • New projects with working products capture the largest share of fresh capital during meme coin rallies

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com